Oncotarget Steps Up Plans for Fighting Cancer through Research Publications

When it comes to cancer management and research, Oncotarget is on the forefront. They use research as a tool to provide content-rich material on Oncology. An article edited by Oncotarget found on scimagoj.com titled Cancer Drugs highlights how effective the editors at Oncotarget are in delivering quality scientific research. The article talks about how cancer drugs are cheap today but unaffordable. The editors at Oncotarget were able to enrich this article with relevant research information with respect to cancer treatment. The article argues about the reasons why the drugs for cancer are unaffordable in spite of being cheap. Through Impact journal, Oncotarget pieces are usually research-driven and target-specific. They are able to avail statistics that are relevant to a particular case study.

IntraGen and Oncotarget Partnership

Recently, IntraGen brought to light their new publication deal with Oncotarget. IntraGen, a Paris-based medical research company, was happy to announce that research results from the miR-31-3p analysis would be published by Oncotarget. The study shows the relationship between miR-31-3p volumes with Metastatic Colorectal Cancer. This publication proves that the analysis of the miR-31-3p levels in a patient suffering from Metastatic Colorectal Cancer is an indicator that the patient can benefit from anti-EGFR therapy. Following this new partnership between the two research firms, Oncotarget is very hopeful of its plans in fighting cancer. They are open to the idea of new partnerships with firms that share their vision and philosophy of fighting cancer.

About Oncotarget Business

Oncotarget is a weekly medical research Oncology journal. The journal was launched in 2010, and its cancer research works are published by their sister company, Impact Journal. The company is made up of a team of experienced and dedicated scientists in various medical disciplines. The editing unit is headed by Mikhail Blagosklonny. The articles are published in English, and currently, Oncotarget releases two research articles each week.

Conclusion

In the field of Oncology, Oncotarget plays a very important role. They are able to provide relevant cancer research results to the public weekly. The team of experts is made up of some of the smartest brains in the medical world. Overall, Oncotarget plan of alleviating cancer is on course and nothing will stop them from realizing this dream.